This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
MK-6884 (Merck M4 positive allosteric modulator PET tracer) 2022 Update: Human Ph. I data disclosed in https://doi.org/10.1126/scitranslmed.abg3684
molecule
2 years ago ●
1 min read
Sulfopin (Weizmann/Harvard selective covalent Pin1 inhibitor)
molecule
2 years ago ●
1 min read
M3814 (Merck KGaA oral DNA-PK selective kinase inhibitor)
molecule
2 years ago ●
1 min read
Remibrutinib (Novartis oral BTK-selective covalent kinase inhibitor clinical candidate)
molecule
2 years ago ●
1 min read
February’s molecule, the Novartis factor B inhibitor LNP023, targets the serine protease factor B (FB), a key node in the complement system.…
molecule
2 years ago ●
1 min read
LMB763 (nidufexor) (Novartis (GNF) oral in vivo selective FXR partial agonist)
molecule
2 years ago ●
1 min read
Load More
